The latter finding may contribute to the extended lifespan of CLL lymphocytes in vivo, particularly in Rai stage 2 and beyond, where IL-10 has been shown to block programmed cell death [33]. This evidence concerns the gene IL10 and B-cell chronic lymphocytic leukemia.